Svärd Anna, Lahti Jouni, Rahkonen Ossi, Lahelma Eero, Lallukka Tea
Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, P.O. Box 20, 00014, Helsinki, Finland.
Finnish Institute of Occupational Health, Helsinki, Finland.
BMC Psychiatry. 2016 Jun 6;16:185. doi: 10.1186/s12888-016-0889-3.
Both obesity and mental health are major public health issues. This study aimed to examine whether overweight and obesity among midlife employees are associated with subsequent psychotropic medication. A further aim was to examine the potential effect of key covariates on the association.
The Helsinki Health Study baseline survey was conducted in 2000-2002 among 40-60-year-old employees of the City of Helsinki, Finland (n = 8960). The participants were classified as of normal weight (18.5-24.9 kg/m(2)), overweight (25-29.9 kg/m(2)), obese (30-34.9 kg/m(2)) or severely obese (≥35 kg/m(2)) based on self-reported body mass index. Data on psychotropic medication purchases from baseline to 2009 were derived from registers of the Social Insurance Institution of Finland. The final analysis included 4760 women and 1338 men. Antidepressants and sedatives were examined separately. Covariates included socio-demographic factors, workload, health behaviours, physical functioning, somatic ill-health and psychotropic medication prior to baseline. Hazard ratios (HR) for the first psychotropic medication purchase were calculated using Cox regression analysis.
Third of women and quarter of men made at least one psychotropic medication purchase during the follow-up. Adjusting for age, obese (HR = 1.57; 95 % CI = 1.10-2.24) and severely obese (HR = 2.15; 95 % CI = 1.29-3.56) men were at risk of having psychotropic medication compared to men of normal weight. These associations disappeared after further adjustment. Severe obesity remained associated with subsequent sedative medication among the men even after full adjustment (HR = 2.12; 95 % CI = 1.17-3.84). No associations were found among the women.
Obese and severely obese men, but not women, were at risk of psychotropic medication. Further studies are needed to deepen understanding of the relationship between obesity and mental ill-health, and the possible protecting effects of age, employment, and living environment.
肥胖和心理健康都是重大的公共卫生问题。本研究旨在探讨中年员工中的超重和肥胖是否与随后使用精神药物有关。另一个目的是研究关键协变量对这种关联的潜在影响。
赫尔辛基健康研究基线调查于2000年至2002年在芬兰赫尔辛基市40至60岁的员工中进行(n = 8960)。根据自我报告的体重指数,参与者被分类为正常体重(18.5至24.9千克/平方米)、超重(25至29.9千克/平方米)、肥胖(30至34.9千克/平方米)或重度肥胖(≥35千克/平方米)。从基线到2009年的精神药物购买数据来自芬兰社会保险机构的登记册。最终分析纳入了4760名女性和1338名男性。分别对 antidepressants(抗抑郁药)和 sedatives(镇静剂)进行了研究。协变量包括社会人口学因素、工作量、健康行为、身体功能、躯体健康不佳以及基线前使用的精神药物。使用Cox回归分析计算首次购买精神药物的风险比(HR)。
在随访期间,三分之一的女性和四分之一的男性至少购买过一次精神药物。在调整年龄后,与正常体重的男性相比,肥胖(HR = 1.57;95%CI = 1.10 - 2.24)和重度肥胖(HR = 2.15;95%CI = 1.29 - 3.56)的男性有使用精神药物的风险。在进一步调整后,这些关联消失了。即使在完全调整后,重度肥胖在男性中仍与随后使用镇静剂有关(HR = 2.12;95%CI = 1.17 - 3.84)。在女性中未发现关联。
肥胖和重度肥胖的男性而非女性有使用精神药物的风险。需要进一步研究以加深对肥胖与精神健康不良之间关系以及年龄、就业和生活环境可能的保护作用的理解。